Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

GRDN stock hub

Guardian Pharmacy Services, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GRDNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

GRDN

In the news

Latest news · GRDN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.6

P25 12.6P50 18.3P75 33.7

Trailing P/E43.3

P25 15P50 23.3P75 38.5

ROE26.9

P25 -106.6P50 -46.9P75 -3.1

ROIC29.3

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GRDN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001802255
Company name	Guardian Pharmacy Services, Inc.
Country	United States
Country code	US
Cusip	40145W101
Employees	3,600
Employees Change	200%
Employees Change Percent	5.88
Enterprise value	$2.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	2024-09-26
Isin	US40145W1018
Last refreshed	2026-05-10
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$36.09
Price currency	USD
Rev Per Employee	404,436.67x
Sector	Healthcare
Sic	5912
Symbol	GRDN
Website	https://guardianpharmacy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.32%
EV Earnings	42.62x
EV Sales Forward	1.54x
EV/EBIT	25.74x
EV/EBITDA	20.39x
EV/FCF	32.3x
EV/Sales	1.55x
FCF yield	3.06%
Forward P/E	28.6x
P/B ratio	10.35x
P/E ratio	43.31x
P/S ratio	1.57x
PEG ratio	2.21x
PS Forward	1.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.03%
EBITDA Margin	7.62%
FCF margin	4.81%
Gross margin	20.93%
Gross Profit	$304.7M
Gross Profit Growth	20.13%
Gross Profit Growth Q	18.59%
Gross Profit Growth3 Y	16.02%
Gross Profit Growth5 Y	15.57%
Net Income	$53.1M
Net Income Growth Q	40.72%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	40.44%
Net Income Growth5 Y	27.55%
Pretax Margin	5.4%
Profit Margin	3.64%
Profit Per Employee	$14,741
Profitable Years	1
ROA	14.43
Roa5y	7.55
ROCE	32.98
ROE	26.91
Roe5y	27.67
ROIC	29.33
Roic5y	22.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.75%
EPS Growth Q	39
EPS Growth Quarters	3
EPS Growth Years	1
FCF Growth	44.72%
FCF Growth Q	-91.12%
FCF Growth3 Y	22.98%
FCF Growth5 Y	9.87%
OCF Growth	32.77%
OCF Growth Q	-65.46%
OCF Growth3 Y	17.13%
OCF Growth5 Y	10.08%
Revenue Growth	13.54x
Revenue Growth Q	2.21x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	15.42x
Revenue Growth5 Y	14.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.83
Assets	$426.9M
Cash	$64.9M
Current Assets	$235.2M
Current Liabilities	$160.5M
Debt	$41.2M
Debt EBITDA	$0.33
Debt Equity	$0.18
Debt FCF	$0.59
Equity	$232.4M
Interest Coverage	135.4
Liabilities	$194.5M
Long Term Assets	$191.8M
Long Term Liabilities	$34M
Net Cash	$23.7M
Net Cash By Market Cap	$1.04
Net Debt EBITDA	$-0.21
Net Debt Equity	$-0.1
Net Debt FCF	$-0.34
Tangible Book Value	$123.7M
Tangible Book Value Per Share	$1.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.46
Inventory Turnover	25.42
Net Working Capital	$17M
Quick ratio	1.1
Working Capital	$74.6M
Working Capital Turnover	$30.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.63%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.72%
200-day SMA	30.07
50-day SMA	36.21
50-day SMA vs 200-day SMA	50over200
All Time High	41.36
All Time High Change	-12.74%
All Time High Date	2026-04-08
All Time Low	14.16
All Time Low Change	154.87%
All Time Low Date	2024-09-26
ATR	1.69
Beta1y	0.46
Beta2y	0.56
Ch YTD	19.94
High	37.35
High52	41.36
High52 Date	2026-04-08
High52ch	-12.74%
Low	35.82
Low52	19.17
Low52 Date	2025-06-16
Low52ch	88.26%
Ma50ch	-0.32%
Premarket Change Percent	0.36
Premarket Price	$36.4
Price vs 200-day SMA	20.02%
RSI	44.55
RSI Monthly	71.97
RSI Weekly	59.78
Sharpe ratio	0.89x
Sortino ratio	1.41
Total Return	-0.63%
Tr YTD	19.94
Tr1m	-8.07%
Tr1w	-3.43%
Tr3m	6.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$43
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.24
Earnings EPS Estimate Growth	60
Earnings Revenue Estimate	329,848,848x
Earnings Revenue Estimate Growth	0.16x
Operating Income	$87.9M
Operating Income Growth Q	56.97
Operating Income Growth3 Y	33.4
Operating Income Growth5 Y	25.52
Operating margin	6.03
Price target	$41.6
Price Target Change	$15.27
Price Target Change Top	$19.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,990,010%
Float Percent	50.52%
Net Borrowing	-4,965,000
Shares Insiders	18.04%
Shares Institutions	41.21%
Shares Out	63,320,634
Shares Qo Q	100.23%
Shares Yo Y	0.63%
Short Float	7.88%
Short Ratio	3.77
Short Shares	3.98

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$58.3M
Average Volume	373,937.8x
Bv Per Share	3.49
CAPEX	$-18.8M
Ch1m	-8.07
Ch1w	-3.43
Ch1y	39.72
Ch3m	6.52
Ch6m	25.31
Change	-0.5%
Change From Open	-1.07
Close	36.27
Days Gap	0.58
Depreciation Amortization	23,044,000
Dollar Volume	19,588,858
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$87.9M
EBITDA	$110.9M
EPS	$0.83
F Score	6
FCF	$70M
FCF EV Yield	3.1x
FCF Per Share	$1.11
Financing CF	-6,443,000
Fiscal Year End	December
Founded	2,004
Goodwill	79,743,000
Graham Number	8.08711
Graham Upside	-77.59
Income Tax	$25.4M
Investing CF	-31,430,000
Ipr	157.8
Iprfo	149.6
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Lynch Fair Value	$20.83
Lynch Upside	-42.28
Ma150	31.81
Ma150ch	13.45%
Ma20	37.17
Ma20ch	-2.91%
Net CF	50,894,000
Next Earnings Date	2026-08-10
Open	36.48
Optionable	Yes
P FCF Ratio	32.64
P OCF Ratio	25.74
Position In Range	17.65
Post Close	36.09
Postmarket Change Percent	-0.08
Postmarket Price	$36.06
Ppne	90,888,000
Pre Close	36.27
Price Date	2026-05-08
Price EBITDA	$20.61
Ptbv Ratio	18.48
Relative Volume	1.45x
Revenue	1,455,972,000x
SBC By Revenue	0.81x
Share Based Comp	11,743,000
Tax By Revenue	1.74x
Tax Rate	32.29%
Tr6m	25.31%
Us State	Georgia
Volume	542,778
Z Score	9.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GRDN pay a dividend?

Capital-return profile for this ticker.

Performance

GRDN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GRDN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+41.2%

Float: +50.5% of shares outstanding

Insider ownership

+18.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GRDN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.5

Neutral momentum band

Price vs 200-day MA

+20.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GRDN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GRDN stock rating?

Guardian Pharmacy Services, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GRDN analysis?

The full report lives at /stocks/GRDN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GRDN?

The latest report frames GRDN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GRDN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.